Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

2013 • 1,523 citations

The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

2005 • 1,038 citations

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

2011 • 822 citations

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

2015 • 579 citations

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis

2012 • 389 citations

Prevalence of HPV After Introduction of the Vaccination Program in the United States

2016 • 351 citations

Triage of HPV positive women in cervical cancer screening

2015 • 280 citations

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

2015 • 264 citations

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

2006 • 235 citations

Are 20 human papillomavirus types causing cervical cancer?

2014 • 233 citations

HPV-FASTER: broadening the scope for prevention of HPV-related cancer

2015 • 188 citations

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

2014 • 173 citations

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland

2014 • 156 citations

Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009–2013

2015 • 120 citations

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes

2016 • 84 citations

Achieving high and equitable coverage of adolescent HPV vaccine in Scotland

2013 • 82 citations

Will cervical screening remain cost‐effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries

2016 • 67 citations

Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study

2016 • 62 citations

Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study

2015 • 61 citations

Prevalence of childhood exanthematic disease antibodies in paramedical students: Need of vaccination

2005 • 54 citations

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study

2016 • 53 citations

Change in Population Prevalences of Human Papillomavirus after Initiation of Vaccination: The High-Throughput HPV Monitoring Study

2014 • 51 citations

Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation

2014 • 42 citations

Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012–2013

2015 • 33 citations

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact

2013 • 30 citations

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines

2010 • 19 citations

Reduction in colposcopy workload and associated clinical activity following human papillomavirus (<scp>HPV</scp>) catch‐up vaccination programme in Scotland: an ecological study

2017 • 16 citations